Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name LY2603618
Trade Name
Synonyms LY-2603618|Rabusertib
Drug Descriptions

Rabusertib (LY2603618) is a small molecule that inhibits CHK1, which may lead to disruption of DNA synthesis, early mitosis, and apoptosis, and may increase tumor cell sensitivity to chemotherapeutics (PMID: 24114124, PMID: 28625637).

DrugClasses CHK1 Inhibitor 17
CAS Registry Number 911222-45-2
NCIT ID C81937


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
AMT-562 + LY2603618 AMT-562 LY2603618 1 0
Cisplatin + LY2603618 + Pemetrexed Disodium Cisplatin LY2603618 Pemetrexed Disodium 0 0
Gemcitabine + LY2603618 Gemcitabine LY2603618 0 0
LB-100 + LY2603618 LB-100 LY2603618 0 0
LY2603618 LY2603618 0 0
LY2603618 + Pemetrexed Disodium LY2603618 Pemetrexed Disodium 0 0
LY2603618 + STP-B LY2603618 STP-B 0 0

Additional content available in CKB BOOST